These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15735069)

  • 1. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study.
    Tai ES; Corella D; Demissie S; Cupples LA; Coltell O; Schaefer EJ; Tucker KL; Ordovas JM;
    J Nutr; 2005 Mar; 135(3):397-403. PubMed ID: 15735069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians.
    Shin MJ; Kanaya AM; Krauss RM
    Atherosclerosis; 2008 Jun; 198(2):313-9. PubMed ID: 18061194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study.
    Tai ES; Demissie S; Cupples LA; Corella D; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):805-10. PubMed ID: 12006394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study.
    Ordovas JM; Corella D; Cupples LA; Demissie S; Kelleher A; Coltell O; Wilson PW; Schaefer EJ; Tucker K
    Am J Clin Nutr; 2002 Jan; 75(1):38-46. PubMed ID: 11756058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study.
    AlSaleh A; Sanders TA; O'Dell SD
    Proc Nutr Soc; 2012 Feb; 71(1):141-53. PubMed ID: 22040870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.
    Volcik KA; Nettleton JA; Ballantyne CM; Boerwinkle E
    Am J Clin Nutr; 2008 Jun; 87(6):1926-31. PubMed ID: 18541586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women.
    Chan E; Tan CS; Deurenberg-Yap M; Chia KS; Chew SK; Tai ES
    Atherosclerosis; 2006 Aug; 187(2):309-15. PubMed ID: 16288935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Lemieux S; Pérusse L; Tchernof A; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(9):482-489. PubMed ID: 15309680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction.
    Olivieri O; Martinelli N; Sandri M; Bassi A; Guarini P; Trabetti E; Pizzolo F; Girelli D; Friso S; Pignatti PF; Corrocher R
    Clin Chem; 2005 Feb; 51(2):360-7. PubMed ID: 15576429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults.
    Park S; Kang S
    J Acad Nutr Diet; 2020 Aug; 120(8):1318-1329.e1. PubMed ID: 32335043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men.
    Paradis AM; Fontaine-Bisson B; Bossé Y; Robitaille J; Lemieux S; Jacques H; Lamarche B; Tchernof A; Couture P; Vohl MC
    Am J Clin Nutr; 2005 Feb; 81(2):523-30. PubMed ID: 15699244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations.
    Alsaleh A; Frost GS; Griffin BA; Lovegrove JA; Jebb SA; Sanders TA; O'Dell SD;
    J Nutrigenet Nutrigenomics; 2011; 4(6):354-66. PubMed ID: 22378291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity.
    Rudkowska I; Caron-Dorval D; Verreault M; Couture P; Deshaies Y; Barbier O; Vohl MC
    Mol Nutr Food Res; 2010 Apr; 54(4):543-50. PubMed ID: 19937854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
    Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
    Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Jamshidi Y; Flavell DM; Hawe E; MacCallum PK; Meade TW; Humphries SE
    Atherosclerosis; 2002 Jul; 163(1):183-92. PubMed ID: 12048138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.